Chromis Lands $3,000,000 Seed Funding Round

  • Feed Type
  • Date
    2/29/2016
  • Company Name
    Chromis
  • Mailing Address
    6605 Nancy Ridge Dr. San Diego, CA 92121 USA
  • Company Description
    Chromis Therapeutics, Inc. (Chromis) is a San Diego-based biopharmaceutical company, focused on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform.
  • Website
    http://www.chromistherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,000,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    The company intends to use the funds to advance its platform of antiviral drugs, including cccDNA inhibitors, entry inhibitors and capsid assembly inhibitors, for the treatment of the Hepatitis B virus (HBV).
  • M&A Terms
  • Venture Investor
    Torrey Pines Investment
  • Venture Investor
    Undisclosed